Intraoperative parathormone measurement in patients with primary hyperparathyroidism: a prospective clinical study

What Was Tested

This clinical trial paper looks at Parathyroid Hormone (PTH 1-84) in the context of hyperparathyroidism.

The objective of this pilot study was to evaluate the use of intraoperative iPTH measurement in combination with bilateral neck exploration in patients with primary hyperparathyroidism.

Who Took Part

According to the abstract, 33 patients were involved.

PubMed indexes the participants as teenagers, adults, middle-aged adults, older adults and people over 80, both men and women.

A prospective study was conducted in a single centre university hospital in Switzerland comprising 33 patients with primary hyperparathyroidism undergoing neck surgery.

Intraoperative iPTH measurement was performed at defined times.

How the Study Was Run

In design terms this was a pilot study.

It is described as a pilot, a small early test of whether a larger Parathyroid Hormone (PTH 1-84) study would be practical.

No routine preoperative localisation studies were conducted.

What Was Measured

PubMed files the paper under topics including Adenoma, Calcium, Hyperparathyroidism, Hyperplasia, Monitoring, Intraoperative, Neck and Outcome Assessment, Health Care.

What This Means in Plain Language

The paper is a pilot study of Parathyroid Hormone (PTH 1-84) in 33 patients in people with hyperparathyroidism.

With fewer than 40 people, it is a small study, so it is better read as an early signal for further research than as a settled answer.

Its findings take up roughly 6 sentences of the abstract and are left out here on purpose; the source paper is the place to read them.

The publication is from 2003 (Swiss medical weekly), a journal based in Switzerland.

More context: the Parathyroid Hormone (PTH 1-84) compound page, Hyperparathyroidism research.